1. Home
  2. BOLD vs LXEH Comparison

BOLD vs LXEH Comparison

Compare BOLD & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • LXEH
  • Stock Information
  • Founded
  • BOLD 2018
  • LXEH 2001
  • Country
  • BOLD United States
  • LXEH China
  • Employees
  • BOLD N/A
  • LXEH N/A
  • Industry
  • BOLD
  • LXEH Other Consumer Services
  • Sector
  • BOLD
  • LXEH Real Estate
  • Exchange
  • BOLD Nasdaq
  • LXEH Nasdaq
  • Market Cap
  • BOLD 30.3M
  • LXEH 25.1M
  • IPO Year
  • BOLD 2024
  • LXEH 2020
  • Fundamental
  • Price
  • BOLD $1.13
  • LXEH $2.00
  • Analyst Decision
  • BOLD Buy
  • LXEH
  • Analyst Count
  • BOLD 3
  • LXEH 0
  • Target Price
  • BOLD $4.00
  • LXEH N/A
  • AVG Volume (30 Days)
  • BOLD 79.0K
  • LXEH 343.6K
  • Earning Date
  • BOLD 05-09-2025
  • LXEH 06-10-2025
  • Dividend Yield
  • BOLD N/A
  • LXEH N/A
  • EPS Growth
  • BOLD N/A
  • LXEH N/A
  • EPS
  • BOLD N/A
  • LXEH N/A
  • Revenue
  • BOLD N/A
  • LXEH $4,493,795.00
  • Revenue This Year
  • BOLD N/A
  • LXEH N/A
  • Revenue Next Year
  • BOLD N/A
  • LXEH N/A
  • P/E Ratio
  • BOLD N/A
  • LXEH N/A
  • Revenue Growth
  • BOLD N/A
  • LXEH N/A
  • 52 Week Low
  • BOLD $1.06
  • LXEH $1.53
  • 52 Week High
  • BOLD $10.13
  • LXEH $50.08
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • LXEH 34.30
  • Support Level
  • BOLD N/A
  • LXEH $1.90
  • Resistance Level
  • BOLD N/A
  • LXEH $2.15
  • Average True Range (ATR)
  • BOLD 0.00
  • LXEH 0.36
  • MACD
  • BOLD 0.00
  • LXEH 0.43
  • Stochastic Oscillator
  • BOLD 0.00
  • LXEH 26.67

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: